Skip to main content

ADVERTISEMENT

paclitaxel-eluting stent

Clinical Trial Update
12/09/2019

William A. Gray, MD, FACC, FSCAI

 

System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania

William A. Gray, MD, FACC, FSCAI   ...
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management talks with IMPERIAL trial co-principal investigator William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Disease; President, Lankenau Heart Institute, Main Line Health, Wynnewood, Pennsylvania.
Vascular Disease Management...
12/09/2019
Vascular Disease Management
FDA Panel
06/22/2019

Frank J. Veith, MD

 

Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New York; Founder and Chairman of VEITHsymposium

Frank J. Veith, MD   Professor of S...
VDM talks with Frank J. Veith, MD, Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New...
VDM talks with Frank J. Veith, MD, Professor of Surgery, New York University-Langone Medical Center and The Cleveland Clinic Lerner College of Medicine; The William J. von Liebig Chair in Vascular Surgery; Cleveland, Ohio and New York, New...
VDM talks with Frank J. Veith,...
06/22/2019
Vascular Disease Management
Editor's Corner
01/21/2019

Craig Walker, MD

 

Cardiovascular Institute of the South, Houma, Louisiana

Craig Walker, MD   Cardiovascular I...
Dr. Walker comments on a hotly debated meta-analysis by Katsanos and colleagues on the risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg.
Dr. Walker comments on a hotly debated meta-analysis by Katsanos and colleagues on the risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg.
Dr. Walker comments on a hotly...
01/21/2019
Vascular Disease Management
Clinical Images
04/25/2017

Akihito Tanaka, MD1,2;  Richard J. Jabbour, MD1,2,3;  Francesco Giannini, MD1,2;  Azeem Latib, MD1,2;  Antonio Colombo, MD1,2

Akihito Tanaka, MD1,2;  Richard J. Ja...
A patient underwent paclitaxel-eluting implantation for a saphenous vein graft stenosis. Follow-up angiogram at 8-months demonstrated no restenosis with multifocal peristent contrast staining. After 10 years, a saphenous vein graft aneurysm...
A patient underwent paclitaxel-eluting implantation for a saphenous vein graft stenosis. Follow-up angiogram at 8-months demonstrated no restenosis with multifocal peristent contrast staining. After 10 years, a saphenous vein graft aneurysm...
A patient underwent...
04/25/2017
Journal of Invasive Cardiology